vs

Side-by-side financial comparison of VISTEON CORP (VC) and West Pharmaceutical Services (WST). Click either name above to swap in a different company.

VISTEON CORP is the larger business by last-quarter revenue ($948.0M vs $805.0M, roughly 1.2× West Pharmaceutical Services). West Pharmaceutical Services runs the higher net margin — 16.4% vs 7.8%, a 8.6% gap on every dollar of revenue. On growth, West Pharmaceutical Services posted the faster year-over-year revenue change (7.5% vs 1.0%). Over the past eight quarters, West Pharmaceutical Services's revenue compounded faster (7.6% CAGR vs 0.8%).

Visteon Corporation (VC) is an American global automotive electronics supplier based in Van Buren Township, Michigan. Visteon designs, engineers, and manufactures vehicle cockpit electronics products, connected car services and electrification products for its customers, which include nearly all of the major automakers worldwide.

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin.

VC vs WST — Head-to-Head

Bigger by revenue
VC
VC
1.2× larger
VC
$948.0M
$805.0M
WST
Growing faster (revenue YoY)
WST
WST
+6.5% gap
WST
7.5%
1.0%
VC
Higher net margin
WST
WST
8.6% more per $
WST
16.4%
7.8%
VC
Faster 2-yr revenue CAGR
WST
WST
Annualised
WST
7.6%
0.8%
VC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
VC
VC
WST
WST
Revenue
$948.0M
$805.0M
Net Profit
$74.0M
$132.1M
Gross Margin
12.9%
37.8%
Operating Margin
6.9%
19.5%
Net Margin
7.8%
16.4%
Revenue YoY
1.0%
7.5%
Net Profit YoY
-40.8%
1.5%
EPS (diluted)
$2.67
$1.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
VC
VC
WST
WST
Q4 25
$948.0M
$805.0M
Q3 25
$917.0M
$804.6M
Q2 25
$969.0M
$766.5M
Q1 25
$934.0M
$698.0M
Q4 24
$939.0M
$748.8M
Q3 24
$980.0M
$746.9M
Q2 24
$1.0B
$702.1M
Q1 24
$933.0M
$695.4M
Net Profit
VC
VC
WST
WST
Q4 25
$74.0M
$132.1M
Q3 25
$-11.0M
$140.0M
Q2 25
$71.0M
$131.8M
Q1 25
$67.0M
$89.8M
Q4 24
$125.0M
$130.1M
Q3 24
$40.0M
$136.0M
Q2 24
$83.0M
$111.3M
Q1 24
$48.0M
$115.3M
Gross Margin
VC
VC
WST
WST
Q4 25
12.9%
37.8%
Q3 25
14.3%
36.6%
Q2 25
14.6%
35.7%
Q1 25
14.8%
33.2%
Q4 24
14.3%
36.5%
Q3 24
13.4%
35.4%
Q2 24
14.5%
32.8%
Q1 24
12.8%
33.1%
Operating Margin
VC
VC
WST
WST
Q4 25
6.9%
19.5%
Q3 25
8.8%
20.8%
Q2 25
10.0%
20.1%
Q1 25
10.2%
15.3%
Q4 24
8.9%
21.3%
Q3 24
5.2%
21.6%
Q2 24
9.9%
18.0%
Q1 24
6.8%
17.7%
Net Margin
VC
VC
WST
WST
Q4 25
7.8%
16.4%
Q3 25
-1.2%
17.4%
Q2 25
7.3%
17.2%
Q1 25
7.2%
12.9%
Q4 24
13.3%
17.4%
Q3 24
4.1%
18.2%
Q2 24
8.2%
15.9%
Q1 24
5.1%
16.6%
EPS (diluted)
VC
VC
WST
WST
Q4 25
$2.67
$1.82
Q3 25
$-0.40
$1.92
Q2 25
$2.57
$1.82
Q1 25
$2.44
$1.23
Q4 24
$4.50
$1.78
Q3 24
$1.43
$1.85
Q2 24
$2.97
$1.51
Q1 24
$1.71
$1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
VC
VC
WST
WST
Cash + ST InvestmentsLiquidity on hand
$771.0M
$791.3M
Total DebtLower is stronger
$202.8M
Stockholders' EquityBook value
$1.6B
$3.2B
Total Assets
$3.4B
$4.3B
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
VC
VC
WST
WST
Q4 25
$771.0M
$791.3M
Q3 25
$762.0M
$628.5M
Q2 25
$668.0M
$509.7M
Q1 25
$655.0M
$404.2M
Q4 24
$623.0M
$484.6M
Q3 24
$550.0M
$490.9M
Q2 24
$505.0M
$446.2M
Q1 24
$504.0M
$601.8M
Total Debt
VC
VC
WST
WST
Q4 25
$202.8M
Q3 25
$202.7M
Q2 25
$202.6M
Q1 25
$202.6M
Q4 24
$202.6M
Q3 24
$202.6M
Q2 24
$205.8M
Q1 24
$206.2M
Stockholders' Equity
VC
VC
WST
WST
Q4 25
$1.6B
$3.2B
Q3 25
$1.5B
$3.1B
Q2 25
$1.5B
$2.9B
Q1 25
$1.4B
$2.7B
Q4 24
$1.3B
$2.7B
Q3 24
$1.3B
$2.8B
Q2 24
$1.2B
$2.6B
Q1 24
$1.1B
$2.7B
Total Assets
VC
VC
WST
WST
Q4 25
$3.4B
$4.3B
Q3 25
$3.3B
$4.1B
Q2 25
$3.3B
$4.0B
Q1 25
$3.1B
$3.6B
Q4 24
$3.0B
$3.6B
Q3 24
$3.0B
$3.7B
Q2 24
$2.8B
$3.5B
Q1 24
$2.8B
$3.6B
Debt / Equity
VC
VC
WST
WST
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.07×
Q1 25
0.08×
Q4 24
0.08×
Q3 24
0.07×
Q2 24
0.08×
Q1 24
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
VC
VC
WST
WST
Operating Cash FlowLast quarter
$118.0M
$251.1M
Free Cash FlowOCF − Capex
$175.0M
FCF MarginFCF / Revenue
21.7%
Capex IntensityCapex / Revenue
9.5%
Cash ConversionOCF / Net Profit
1.59×
1.90×
TTM Free Cash FlowTrailing 4 quarters
$468.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
VC
VC
WST
WST
Q4 25
$118.0M
$251.1M
Q3 25
$127.0M
$197.2M
Q2 25
$95.0M
$177.1M
Q1 25
$70.0M
$129.4M
Q4 24
$203.0M
$190.1M
Q3 24
$98.0M
$180.1M
Q2 24
$57.0M
$165.0M
Q1 24
$69.0M
$118.2M
Free Cash Flow
VC
VC
WST
WST
Q4 25
$175.0M
Q3 25
$133.9M
Q2 25
$101.9M
Q1 25
$58.1M
Q4 24
$85.2M
Q3 24
$98.8M
Q2 24
$64.8M
Q1 24
$27.6M
FCF Margin
VC
VC
WST
WST
Q4 25
21.7%
Q3 25
16.6%
Q2 25
13.3%
Q1 25
8.3%
Q4 24
11.4%
Q3 24
13.2%
Q2 24
9.2%
Q1 24
4.0%
Capex Intensity
VC
VC
WST
WST
Q4 25
9.5%
Q3 25
7.9%
Q2 25
9.8%
Q1 25
10.2%
Q4 24
14.0%
Q3 24
10.9%
Q2 24
14.3%
Q1 24
13.0%
Cash Conversion
VC
VC
WST
WST
Q4 25
1.59×
1.90×
Q3 25
1.41×
Q2 25
1.34×
1.34×
Q1 25
1.04×
1.44×
Q4 24
1.62×
1.46×
Q3 24
2.45×
1.32×
Q2 24
0.69×
1.48×
Q1 24
1.44×
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

VC
VC

Audioandinfotainment$508.0M54%
Informationdisplays$428.0M45%

WST
WST

Proprietary Products$661.8M82%
Contract Manufactured Products$143.2M18%
Affiliated Entity$3.3M0%

Related Comparisons